Image

Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling

This study tests a new way to diagnose serious infections quickly.

Recruiting
18 years and older
All
Phase N/A

Necrotizing Soft Tissue Infections (NSTIs) are serious infections that can quickly become dangerous, leading to organ failure or even death. This study aims to improve how we detect NSTIs using a special dye called **Indocyanine Green (ICG)**. ICG is a safe dye approved by the FDA that helps doctors see blood flow in tissues. When injected, it lights up under a special camera, showing if blood vessels are blocked, which is common in NSTIs. This study involves taking pictures of the dye in action at eight medical centers to check its accuracy in diagnosing NSTIs.

**Key Points:**

  • Study is observational, meaning it doesn’t change your current treatment.
  • You need to be 18 or older and suspected of having NSTIs to participate.
  • Pregnant/nursing women or those allergic to ICG cannot join.

By using this imaging method, doctors hope to catch NSTIs earlier, helping improve patient outcomes and survival rates. This study will compare the new method to current tests to find the best way to diagnose NSTIs.

Study details
    Necrotizing Fascitis

NCT06877793

Eric R. Henderson

17 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.